articleJournal of Cerebral Blood Flow & MetabolismOct 31, 2006BRONZE OA

Transport Pathways for Clearance of Human Alzheimer's Amyloid β-Peptide and Apolipoproteins E and J in the Mouse Central Nervous System

University of Rochester Medical Center · Washington University in St. Louis

PubMed
Indexed incrossrefpubmed

Abstract

Amyloid beta-peptide (Abeta) clearance from the central nervous system (CNS) maintains its low levels in brain. In Alzheimer's disease, Abeta accumulates in brain possibly because of its faulty CNS clearance and a deficient efflux across the blood-brain barrier (BBB). By using human-specific enzyme-linked immunosorbent assays, we measured a rapid 30 mins efflux at the BBB and transport via the interstitial fluid (ISF) bulk flow of human-unlabeled Abeta and of Abeta transport proteins, apolipoprotein E (apoE) and apoJ in mice. We show (i) Abeta40 is cleared rapidly across the BBB via low-density lipoprotein receptor-related protein (LRP)1 at a rate of 0.21 pmol/min g ISF or 6-fold faster than via the ISF flow;…

Citation impact

671
total citations
FWCI
11.14
Percentile
100%
References
43
Citations per year

Authors

7

Topics & keywords

Keywords
  • Central nervous system
  • Amyloid (mycology)
  • Peptide
  • Neuroscience
  • P3 peptide
  • Amyloid precursor protein
  • Alzheimer's disease
  • Chemistry
UN Sustainable Development Goals
  • No poverty
No related works found for this paper.